Welcome to our dedicated page for Core Laboratories news (Ticker: CLB), a resource for investors and traders seeking the latest updates and insights on Core Laboratories stock.
Core Laboratories Inc. (NYSE: CLB) is an oilfield services company that focuses on reservoir description and production enhancement services and products for global oil and gas operators. The CLB news page on Stock Titan aggregates company announcements, earnings releases, and operational updates that the company issues through press releases and SEC-related disclosures.
Investors and industry followers can use this news feed to review Core Laboratories’ quarterly earnings reports, which typically include segment performance for Reservoir Description and Production Enhancement, commentary on international and offshore activity, and details on free cash flow, capital allocation, and dividends. The company’s news also covers strategic developments such as the opening of its unconventional core analysis laboratory in Dammam, Saudi Arabia, and the acquisition of Brazil-based geological services provider Solintec.
Core Laboratories’ updates frequently describe how its proprietary technologies—such as PRISM™ workflows, diagnostic tracers, and specialized energetic systems—are applied in specific client projects across regions including the Middle East, Africa, South America, the North Sea, and other key oil-producing basins. These case studies provide context on how the company’s services are used in deepwater exploration, unconventional reservoir evaluation, plug and abandonment operations, and geothermal projects.
By following CLB news, readers can monitor scheduled earnings conference calls, dividend declarations, changes to credit facilities disclosed via 8-K filings, and management’s commentary on industry conditions. Bookmark this page to access a consolidated view of Core Laboratories’ latest public communications as they are released.
Core Laboratories (NYSE: CLB) reported Q4 2025 revenue of $138.3M, up 3% sequentially and 7% year-over-year, with GAAP operating income of $15.8M and GAAP EPS of $0.15. Full year 2025 revenue was $526.5M, GAAP operating income $56.5M, and GAAP EPS $0.68. The company generated $26.0M free cash flow for 2025, reduced net debt by $18.7M (over 17%), repurchased ~1.2M shares for $15.5M, and declared a quarterly cash dividend of $0.01 per share.
Core Laboratories (NYSE: CLB) will release fourth quarter 2025 earnings after market close on February 4, 2026 and host a conference call on February 5, 2026 at 7:30 a.m. CST / 8:30 a.m. EST.
Larry Bruno, Chairman and CEO; Chris Hill, CFO; and Gwen Gresham, SVP Corporate Development and Investor Relations will discuss financial and operational results. The earnings release, live listen-only webcast, replay and transcript will be available at www.corelab.com/investors. Analysts needing dial-in details may contact investor.relations@corelab.com. The company operates more than 70 offices in 50+ countries providing reservoir description and production enhancement services.
Core Laboratories (NYSE: CLB) will release fourth quarter 2025 earnings after market close on February 4, 2026 and host a conference call on February 5, 2026 at 7:30 a.m. CST / 8:30 a.m. EST.
Larry Bruno, Chairman and CEO; Chris Hill, CFO; and Gwen Gresham, SVP Corporate Development and Investor Relations will discuss financial and operational results. The earnings release, live listen-only webcast, replay and transcript will be available at www.corelab.com/investors. Analysts needing dial-in details may contact investor.relations@corelab.com. The company operates more than 70 offices in 50+ countries providing reservoir description and production enhancement services.
Core Laboratories (NYSE: CLB) reported Q3 2025 revenue of $134.5M, GAAP operating income of $20.9M and GAAP EPS of $0.30. Operating income, ex-items, was $16.6M and EPS, ex-items, was $0.22. The company generated $6.5M free cash flow, repurchased 462,248 shares for $5.0M (≈1% of outstanding shares), and reduced net debt by $3.4M to $91.4M, lowering leverage to 1.10. On Oct 1, 2025 Core completed the acquisition of Brazil-based Solintec for an initial cash payment of $2.3M plus an earnout up to $3.7M. Q4 2025 guidance: revenue $132M–$136M, operating income $14M–$16.1M, EPS $0.18–$0.22. The Board approved a quarterly cash dividend of $0.01 per share.
Core Laboratories (NYSE: CLB) reported Q3 2025 revenue of $134.5M, GAAP operating income of $20.9M and GAAP EPS of $0.30. Operating income, ex-items, was $16.6M and EPS, ex-items, was $0.22. The company generated $6.5M free cash flow, repurchased 462,248 shares for $5.0M (≈1% of outstanding shares), and reduced net debt by $3.4M to $91.4M, lowering leverage to 1.10. On Oct 1, 2025 Core completed the acquisition of Brazil-based Solintec for an initial cash payment of $2.3M plus an earnout up to $3.7M. Q4 2025 guidance: revenue $132M–$136M, operating income $14M–$16.1M, EPS $0.18–$0.22. The Board approved a quarterly cash dividend of $0.01 per share.
Core Laboratories (NYSE: CLB) has announced the strategic acquisition of Solintec, a leading Brazil-based integrated geological services company. The acquisition strengthens Core Lab's presence in Brazil's oil and gas sector, where Solintec has been serving national and international companies for over 30 years.
Solintec's modern laboratory facilities provide in-country mineralogic and sedimentary analysis capabilities, which, combined with Core Lab's proprietary dual-energy tomography, will enhance geological assessment services for Brazil's complex offshore pre-salt and onshore projects. The companies have been collaborating through a technical services arrangement since 2022.
This strategic move aligns with Core Lab's investment strategy in key growth markets, positioning the company to capitalize on Brazil's emergence as a leading non-OPEC producer.
Core Laboratories (NYSE:CLB), a global leader in reservoir description and production enhancement services, has scheduled its Q3 2025 earnings conference call for October 23, 2025, at 7:30 a.m. CDT. The company will release its earnings report after market close on October 22, 2025.
The call will feature CEO Larry Bruno, CFO Chris Hill, and SVP Corporate Development Gwen Gresham discussing financial and operational results. Investors can access the webcast through Core Laboratories' website, with replay and transcript available post-call.
Core Laboratories (NYSE:CLB) reported Q2 2025 results with revenue of $130.2 million, up 5% sequentially but flat year-over-year. Operating income was $15.3 million, with operating margins ex-items of 11%. The company posted GAAP EPS of $0.22 (ex-items $0.19).
The Reservoir Description segment generated revenue of $86.3 million, up 7% sequentially, while Production Enhancement posted revenue of $43.9 million, up 3% sequentially. Core Lab opened a new Unconventional Core Analysis Laboratory in Dammam, Saudi Arabia, strengthening its Middle East presence.
The company generated free cash flow of $10.4 million, reduced net debt by $9.1 million, and improved its debt leverage ratio to 1.27. Core Lab repurchased 237,632 shares worth $2.7 million and declared a quarterly dividend of $0.01 per share.
Core Laboratories (NYSE: CLB), a global leader in reservoir description and production enhancement services, has scheduled its second quarter 2025 earnings conference call for July 24, 2025, at 7:30 a.m. CDT / 8:30 a.m. EST. The earnings release will be issued after market close on July 23, 2025.
The company's leadership team, including CEO Larry Bruno, CFO Chris Hill, and SVP Gwen Gresham, will discuss financial and operational results. Investors can access the webcast through Core Laboratories' website, with replay and transcript available post-call. The company maintains a strong global presence with over 70 offices across more than 50 countries.
Core Laboratories (NYSE: CLB) has announced the opening of a new Unconventional Core Analysis Laboratory in Dammam, Saudi Arabia, developed in partnership with Abdulla Fouad Group. The state-of-the-art facility features advanced proprietary instrumentation for comprehensive core and fluid analysis services focused on unconventional reservoirs.
The laboratory utilizes cutting-edge technologies including dual energy CT-scanning, high-frequency Nuclear Magnetic Resonance (NMR), and Core's proprietary PRISM™ workflow to provide detailed reservoir rock and fluid characterization. CEO Larry Bruno emphasized that this expansion represents a significant milestone in supporting the energy sector's evolving needs. The facility aims to become a central hub for unconventional core analysis in the Middle East region.